COMPASS Pathways plc

NasdaqGS CMPS

COMPASS Pathways plc Revenue for the year ending December 31, 2023: USD 0.00

COMPASS Pathways plc Revenue is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

COMPASS Pathways plc Revenue for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
COMPASS Pathways plc Revenue for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
COMPASS Pathways plc Revenue for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
COMPASS Pathways plc Revenue for the year ending December 31, 2019 was USD 0.00, a 0.00% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

NasdaqGS: CMPS

COMPASS Pathways plc

CEO	Mr. Kabir Kumar Nath M.A., M.B.A.
IPO Date	Sept. 18, 2020
Location	United Kingdom
Headquarters	33 Broadwick Street
Employees	186
Sector	Health Care
Industries Pharmaceuticals Mental Health

Description

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Key trends

Past 5 years